Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Mayo Clinic Laboratories, |
RCV001509181 | SCV001715753 | uncertain significance | not provided | 2020-08-13 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002488314 | SCV002791826 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J; Tibial muscular dystrophy; Myopathy, myofibrillar, 9, with early respiratory failure; Early-onset myopathy with fatal cardiomyopathy; Hypertrophic cardiomyopathy 9 | 2021-09-10 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV001509181 | SCV003819080 | uncertain significance | not provided | 2019-10-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001509181 | SCV005439338 | uncertain significance | not provided | 2024-06-17 | criteria provided, single submitter | clinical testing | Identified in a patient with DCM in published literature (PMID: 31983221); Not observed at significant frequency in large population cohorts (gnomAD); Missense variant in a gene in which most reported pathogenic variants are truncating/loss of function; This variant is associated with the following publications: (PMID: 31983221) |